Journal of Emergency Health Care
Formerly known as: International Journal of Medical Investigation
Volume 8, Issue 4 (12-2019)
J Emerg Health Care 2019, 8(4): 9-15 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Saadat P, Hojjati S M M, Khatir A A, Ahangar A A, Naghshineh H. Epidemiology of Multiple Sclerosis: A Narrative Review. J Emerg Health Care 2019; 8 (4) :9-15
URL: http://intjmi.com/article-1-451-en.html
URL: http://intjmi.com/article-1-451-en.html
Payam Saadat 
, Seyed Mohammad Masood Hojjati * , Ali Alizadeh Khatir , Alijan Ahmadi Ahangar , Hoda Naghshineh
, Seyed Mohammad Masood Hojjati * , Ali Alizadeh Khatir , Alijan Ahmadi Ahangar , Hoda Naghshineh
1. Mobility Impairment Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran 2. Department of Neurology, Babol University of Medical Sciences, Babol, Iran
Abstract: (5339 Views)
Multiple Sclerosis (MS) is an autoimmune, inflammatory, and chronic disease that develops due to Myelin destruction lesions in the white matter of the brain, the spinal cord and the optic nerve. Due to the impact of the effect of cognition and the epidemiology of MS, our aim is to review the epidemiology of MS. In this review, by using keywords including Multiple Sclerosis and through searches on valid scientific databases such as Google Scholar, PubMed, ScienceDirect, Web of Science, Ovid Medline and WHO site, articles and dissertations from 1990 to 2019 were found and reviewed. The studies show that many factors such as age, gender, geographical location, etc. influence the increasing incidence of MS. In this review, we aimed to review the epidemiology of MS.
References
1. 1. Marrie RA, Horwitz RI. Emerging effects of comorbidities on multiple sclerosis. The Lancet Neurology. 2010;9(8):820-8.
2. Hojjati SM, Hojjati SA, Baes M, Bijani A. Relation between EDSS and monosymptomatic or polysymptomatic onset in clinical manifestations of multiple sclerosis in Babol, northern Iran. Caspian J Intern Med. 2014;5(1):5–8.
3. Motl RW, Snook EM, Wynn DR, Vollmer T. Physical activity correlates with neurological impairment and disability in multiple sclerosis. The Journal of nervous and mental disease. 2008;196(6):492-5.
4. Hojjati SM, Zarghami A, Hojjati SA, Baes M. Optic neuritis, the most common initial presenting manifestation of multiple sclerosis in northern Iran. Caspian J Intern Med. 2015;6(3):151–5.
5. Pazokian M, Shaban M, Zakerimoghdam M, Mehran A, Sanglaje B. The effect of stretching together aerobic exercises on fatigue level in multiple sclerosis patients refer to MS society of Iran those suffer from fatigue. Journal of Holistic Nursing And Midwifery. 2012;22(2):18-24.
6. Hojati S, Zarghami A, Yousefzad T, Hojati S, Baes M. Epidemiological Features of 263 Patients with Multiple Sclerosis Residing in Babol, Iran. J Babol Univ Med Sci. 2016;18(1):52–6.
7. Matuska K, Mathiowetz V, Finlayson M. Use and perceived effectiveness of energy conservation strategies for managing multiple sclerosis fatigue. The American journal of occupational therapy. 2007;61(1):62-9.
8. Masoudi R, Mohamady E, Nabavi M. Effect of self-care program on Ourem method on physical dimension of quality of life of Ms patient. Persian J Shahrekord Med Univ. 2008;1387(10):2.
9. Shafizadeh M, Platt GK, Mohammadi B. Effects of different focus of attention rehabilitative training on gait performance in Multiple Sclerosis patients. Journal of bodywork and movement therapies. 2013;17(1):28-34.
10. Eftekhari E, Nikbakht H, RABIEI K, Etemadifar M. Effect of endurance training on aerobic power and quality of life in female patients with multiple sclerosis. 2008.
11. Naghshineh H, Hojjati SMM, Alizadeh Khatir A, Saadat P, Ahangar AA. Can environmental factors increase the risk of multiple sclerosis? A narrative review. Biomedical Research and Therapy. 2019;6(12):3513-3517.
12. Kargarfard M, Etemadifar M, Asfarjani F, Mehrabi M, Kordavani L. Changes in quality of life and fatigue in women with multiple sclerosis after 8 weeks of aquatic exercise training. Journal of fundamentals of mental health. 2010;12(3):562-73.
13. Sakkas GK, Hadjigeorgiou GM, Karatzaferi C, Maridaki MD, Giannaki CD, Mertens PR, et al. Intradialytic aerobic exercise training ameliorates symptoms of restless legs syndrome and improves functional capacity in patients on hemodialysis: a pilot study. ASAIO Journal. 2008;54(2):185-90.
14. Ohayon MM, Roth T. Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. Journal of psychosomatic research. 2002;53(1):547-54.
15. Taylor N, Dodd K, Prasad D, Denisenko S. Progressive resistance exercise for people with multiple sclerosis. Disability and rehabilitation. 2006;28(18):1119-26.
16. Petajan JH, Gappmaier E, White AT, Spencer MK, Mino L, Hicks RW. Impact of aerobic training on fitness and quality of life in multiple sclerosis. Annals of neurology. 1996;39(4):432-41.
17. Mostert S, Kesselring J. Effects of a short-term exercise training program on aerobic fitness, fatigue, health perception and activity level of subjects with multiple sclerosis. Multiple Sclerosis Journal. 2002;8(2):161-8.
18. Monireh MN, Hossein S, Hossini F. Effects of selected combined training on balance and functional capacity in women with multiple sclerosis. WASJ. 2012;16:1019-26.
19. Golzari Z, Shabkhiz F, Soudi S, Kordi MR, Hashemi SM. Combined exercise training reduces IFN-γ and IL-17 levels in the plasma and the supernatant of peripheral blood mononuclear cells in women with multiple sclerosis. International immunopharmacology. 2010;10(11):1415-9.
20. Oken BS, Kishiyama S, Zajdel D, Bourdette D, Carlsen J, Haas M, et al. Randomized controlled trial of yoga and exercise in multiple sclerosis. Neurology. 2004;62(11):2058-64.
21. Alphonsus KB, Su Y, D’Arcy C. The effect of exercise, yoga and physiotherapy on the quality of life of people with multiple sclerosis: Systematic review and meta-analysis. Complementary Therapies in Medicine. 2019;43:188-95.
22. Sutcher H. Hypnosis as adjunctive therapy for multiple sclerosis: a progress report. American Journal of Clinical Hypnosis. 1997;39(4):283-90.
23. Braley TJ, Segal BM, Chervin RD. Hypnotic use and fatigue in multiple sclerosis. Sleep medicine. 2015;16(1):131-7.
24. Armutlu K, Karabudak R, Nurlu G. Physiotherapy approaches in the treatment of ataxic multiple sclerosis: a pilot study. Neurorehabilitation and neural repair. 2001;15(3):203-11.
25. Wiles C. Physiotherapy and related activities in multiple sclerosis. Multiple Sclerosis Journal. 2008;14(7):863-71.
26. Mount J, Dacko S. Effects of dorsiflexor endurance exercises on foot drop secondary to multiple sclerosis: a pilot study. NeuroRehabilitation. 2006;21(1):43-50.
27. Jailkhani S, Naik J, Thakur M, Langare S, Pandey V. Retrospective analysis of poisoning cases admitted in a tertiary care hospital. Int J Recent Trends Sci Technol. 2014;10(2):365-8.
28. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Archives of neurology. 1989;46(10):1121-3.
29. Fricska-Nagy Z, Bencsik K, Rajda C, Füvesi J, Honti V, Csepany T, et al. Epidemiology of familial multiple sclerosis in Hungary. Multiple Sclerosis Journal. 2007;13(2):260-1.
30. Ebers G, Koopman W, Hader W, Sadovnick A, Kremenchutzky M, Mandalfino P, et al. The natural history of multiple sclerosis: a geographically based study: 8: familial multiple sclerosis. Brain. 2000;123(3):641-9.
31. Marrosu MG, Lai M, Cocco E, Loi V, Spinicci G, Pischedda M, et al. Genetic factors and the founder effect explain familial MS in Sardinia. Neurology. 2002;58(2):283-8.
32. Rampello A, Franceschini M, Piepoli M, Antenucci R, Lenti G, Olivieri D, et al. Effect of aerobic training on walking capacity and maximal exercise tolerance in patients with multiple sclerosis: a randomized crossover controlled study. Physical therapy. 2007;87(5):545-55.
33. Kahana E. Epidemiologic studies of multiple sclerosis: a review. Biomedicine & pharmacotherapy= Biomedecine & pharmacotherapie. 2000;54(2):100-2.
34. Willer CJ, Dyment DA, Cherny S, Ramagopalan SV, Herrera BM, Morrison KM, et al. A genome-wide scan in forty large pedigrees with multiple sclerosis. Journal of human genetics. 2007;52(12):955.
35. Kremenchutzky M, Cottrell D, Rice G, Hader W, Baskerville J, Koopman W, et al. The natural history of multiple sclerosis: a geographically based study: 7. Progressive–relapsing and relapsing–progressive multiple sclerosis: a re-evaluation. Brain. 1999;122(10):1941-50.
36. Solaro C, Allemani C, Uccelli MM, Canevari E, Dagnino N, Pizio R, et al. The prevalence of multiple sclerosis in the north–west Italian province of Genoa. Journal of neurology. 2005;252(4):436-40.
37. Dalla Costa G, Giordano A, Romeo M, Sangalli F, Comi G, Martinelli V. Digital epidemiology confirms a latitude gradient of MS in France. Multiple sclerosis and related disorders. 2018;20:129-31.
38. Boyko A, Smirnova N, Petrov S, Gusev E. Epidemiology of MS in Russia, a historical review. Multiple Sclerosis and Demyelinating Disorders. 2016;1(1):13.
39. Pugliatti M, Rosati G, Carton H, Riise T, Drulovic J, Vécsei L, et al. The epidemiology of multiple sclerosis in Europe. European journal of Neurology. 2006;13(7):700-22.
40. Kaufman MD, Johnson SK, Moyer D, Bivens J, Norton HJ. Multiple sclerosis: severity and progression rate in African Americans compared with whites. American journal of physical medicine & rehabilitation. 2003;82(8):582-90.
41. Kantarci O, Wingerchuk D. Epidemiology and natural history of multiple sclerosis: new insights. Current opinion in neurology. 2006;19(3):248-54.
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |